Fresenius Medical Care AG

Equities

FME

DE0005785802

Healthcare Facilities & Services

Market Closed - Xetra 11:36:09 2024-04-18 am EDT 5-day change 1st Jan Change
36.43 EUR +2.50% Intraday chart for Fresenius Medical Care AG +3.17% -4.03%
This Alphavalue article, the European leader in independent research, is only available to subscribers .
Alphavalue is exclusively on MarketScreener.
To unlock the article, SUBSCRIBE!
Already a customer? Log In
STOXX 600 nears six-week low on geopolitical jitters; Ericsson shines RE
Fresenius at a two-month high - Tyenne launch and fantasy figures DP
Fresenius at two-month high - Tyenne launch a milestone DP
European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : JP Morgan gives a Sell rating ZD
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Flat in Tuesday Trading MT
Fresenius Medical Care Launches Augmented Reality for Training on Kidney Replacement Therapy Device CI
Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar MT
Fresenius Settles With Johnson & Johnson to Market Stelara Alternative DJ
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Friday Trading MT
Fresenius Medical Care AG Appoints Jörg Häring as New Global Head of Legal, Compliance and Human Resources and Also Assume the Role of Labor Director, Effective from June 1, 2024 CI
European Equities Traded in the US as American Depositary Receipts Advance Wednesday MT
ADRs Slump, Quoin Pharmaceuticals Ltd. Declines 48.3% DJ
Sector Update: Health Care Stocks Retreating Late Afternoon MT
Sector Update: Health Care Stocks Lower Tuesday Afternoon MT
Fresenius Medical Care to Sell Dialysis Clinics in Brazil, Colombia, Chile, Ecuador to DaVita MT
Dialysis providers gain as investors focus on cardiac benefits after Ozempic's latest data RE
European Equities Traded in the US as American Depositary Receipts Decline Tuesday MT
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Barclays reaffirms its Neutral rating ZD
FMC FRESENIUS MEDICAL CARE AG & CO KGAA : Berenberg keeps its Buy rating ZD
Dialysis firms gain as Ozempic kidney trial data disappoints RE
Novo Nordisk's kidney trial cuts cardiac risk, death by 24% RE
Novo Nordisk Ozempic trial delays progression of chronic kidney disease RE
DaVita Inc. agreed to acquire Dialysis clinic networks in Colombia from Fresenius Medical Care AG. CI
Chart Fresenius Medical Care AG
More charts
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
36.43 EUR
Average target price
38.95 EUR
Spread / Average Target
+6.92%
Consensus
  1. Stock Market
  2. Equities
  3. FME Stock
  4. News Fresenius Medical Care AG
  5. Fresenius Medical Care: Barebone 2023 profitability is a much lower starting point